| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Dong-Yeon Kim CEO | TWSE Exchange | TW0005283006 ISIN |
| KR Country | 666 Employees | 28 Aug 2026 Last Dividend | 28 Aug 2026 Last Split | - IPO Date |
Ilyang Pharmaceutical Co.,Ltd is a prominent entity in the pharmaceutical industry, primarily operating within South Korea. The inception of the company dates back to 1946, initially known as Il-Yang Pharm. Ind. Co. before it underwent a name change to Ilyang Pharmaceutical Co., Ltd. in May 1991. The company’s headquarters are situated in Yongin, South Korea. Throughout its rich history, Ilyang Pharmaceutical Co.,Ltd has expanded both its product range and market reach, including exports of its products to international markets.
The company’s portfolio is expansive, covering a wide spectrum of medical and health-related products and services: